ATE278415T1 - Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum - Google Patents

Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Info

Publication number
ATE278415T1
ATE278415T1 AT00123426T AT00123426T ATE278415T1 AT E278415 T1 ATE278415 T1 AT E278415T1 AT 00123426 T AT00123426 T AT 00123426T AT 00123426 T AT00123426 T AT 00123426T AT E278415 T1 ATE278415 T1 AT E278415T1
Authority
AT
Austria
Prior art keywords
growth factor
epidermal growth
egf
animal
preparing
Prior art date
Application number
AT00123426T
Other languages
English (en)
Inventor
Andre G Buret
James A Hardin
Grant D Gall
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of ATE278415T1 publication Critical patent/ATE278415T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00123426T 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum ATE278415T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
ATE278415T1 true ATE278415T1 (de) 2004-10-15

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
AT00123426T ATE278415T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
AT04019831T ATE357927T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
AT96913397T ATE203912T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT04019831T ATE357927T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
AT96913397T ATE203912T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Country Status (12)

Country Link
US (2) US5753622A (de)
EP (3) EP0824357B1 (de)
JP (1) JP3549541B2 (de)
AT (3) ATE278415T1 (de)
AU (1) AU704675B2 (de)
CA (2) CA2492724C (de)
DE (3) DE69633583T2 (de)
DK (3) DK1092437T3 (de)
ES (2) ES2285320T3 (de)
NZ (2) NZ307134A (de)
PT (1) PT1479394E (de)
WO (1) WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6967090B2 (en) * 2001-05-18 2005-11-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Nucleic acid and protein sequences of bovine epidermal growth factor
CA2464609A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
DE60319822T2 (de) 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
CA2582958A1 (en) * 2004-09-30 2006-04-06 University Technologies International Inc. Rehydration compositions comprising epidermal growth factor
WO2007011702A2 (en) * 2005-07-15 2007-01-25 The University Of North Carolina At Chapel Hill Use of egfr inhibitors to prevent or treat obesity
DK2119450T3 (da) 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
JPH01501707A (ja) * 1986-12-11 1989-06-15 ブリティッシュ・テクノロジー・グループ・リミテッド 表皮成長因子の使用におけるまたは関する改良
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
DE69614377T2 (de) 2002-05-23
EP1092437B1 (de) 2004-10-06
PT1479394E (pt) 2007-04-30
DK1092437T3 (da) 2005-01-31
NZ307134A (en) 2000-02-28
EP0824357B1 (de) 2001-08-08
DK1479394T3 (da) 2007-06-11
CA2220434C (en) 2005-02-22
DK0824357T3 (da) 2001-10-08
EP1479394A1 (de) 2004-11-24
EP1479394B1 (de) 2007-03-28
DE69633583T2 (de) 2006-02-23
DE69637002T2 (de) 2007-08-16
US6656907B1 (en) 2003-12-02
CA2492724A1 (en) 1996-11-14
ATE357927T1 (de) 2007-04-15
ES2285320T3 (es) 2007-11-16
HK1072894A1 (en) 2005-09-16
CA2220434A1 (en) 1996-11-14
NZ501482A (en) 2004-12-24
CA2492724C (en) 2010-08-03
ATE203912T1 (de) 2001-08-15
ES2226681T3 (es) 2005-04-01
DE69633583D1 (de) 2004-11-11
DE69637002D1 (de) 2007-05-10
JP3549541B2 (ja) 2004-08-04
EP0824357A1 (de) 1998-02-25
JPH11505528A (ja) 1999-05-21
AU704675B2 (en) 1999-04-29
WO1996035445A1 (en) 1996-11-14
US5753622A (en) 1998-05-19
DE69614377D1 (de) 2001-09-13
EP1092437A1 (de) 2001-04-18
AU5641196A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
DE69633583D1 (de) Verwendung des epidermalen Wachstumsfaktors als Magen-Darm Therapeutikum
GR3006124T3 (de)
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
AU1277688A (en) Sustained release compositions for parenteral administration and their use
ATE283241T1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE59505618D1 (de) Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren
DK267586A (da) Dyrestraeelse samt fremgangsmaade til fremstilling heraf
HUT69990A (en) Method and composition for determining the immunological activity of bioactive substances
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE8049T1 (de) 1,3-dioxan-5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE3686559D1 (de) Verwendung von phenaethanolaminen zum verbessern des fettgehaltes von saumilch.
SU1522498A1 (ru) Дезинфицирующее средство
DE69313850D1 (de) Veterinaerprodukt zur rehydration
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE145197T1 (de) Lagerstabile lösungen von carbonisiertem magnesiumethylat in ethanol sowie deren herstellung und verwendung
ATE124264T1 (de) Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen.
GR3024709T3 (en) Novel cytarabine derivatives, their production and use
UA19671A (uk) Спосіб боротьби з фітопатогеhhими мікрооргаhізмами
ATE246932T1 (de) Methode zur herstellung eines wirkstoffes zur behandlung von ulcera des organismus
MD512C2 (ro) Inhibitor dezvoltării mugurilor la altoaiele viţei de vie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1092437

Country of ref document: EP

REN Ceased due to non-payment of the annual fee